Conceptualising engagement with HIV care for people on treatment: the Indicators of HIV Care and AntiRetroviral Engagement (InCARE) Framework.
Adherence
Antiretroviral therapy
Engagement
HIV care continuum
Retention
Self-management
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
04 May 2023
04 May 2023
Historique:
received:
12
08
2022
accepted:
14
04
2023
medline:
8
5
2023
pubmed:
5
5
2023
entrez:
4
5
2023
Statut:
epublish
Résumé
As the crisis-based approach to HIV care evolves to chronic disease management, supporting ongoing engagement with HIV care is increasingly important to achieve long-term treatment success. However, 'engagement' is a complex concept and ambiguous definitions limit its evaluation. To guide engagement evaluation and development of interventions to improve HIV outcomes, we sought to identify critical, measurable dimensions of engagement with HIV care for people on treatment from a health service-delivery perspective. We used a pragmatic, iterative approach to develop a framework, combining insights from researcher experience, a narrative literature review, framework mapping, expert stakeholder input and a formal scoping review of engagement measures. These inputs helped to refine the inclusion and definition of important elements of engagement behaviour that could be evaluated by the health system. The final framework presents engagement with HIV care as a dynamic behaviour that people practice rather than an individual characteristic or permanent state, so that people can be variably engaged at different points in their treatment journey. Engagement with HIV care for those on treatment is represented by three measurable dimensions: 'retention' (interaction with health services), 'adherence' (pill-taking behaviour), and 'active self-management' (ownership and self-management of care). Engagement is the product of wider contextual, health system and personal factors, and engagement in all dimensions facilitates successful treatment outcomes, such as virologic suppression and good health. While retention and adherence together may lead to treatment success at a particular point, this framework hypothesises that active self-management sustains treatment success over time. Thus, evaluation of all three core dimensions is crucial to realise the individual, societal and public health benefits of antiretroviral treatment programmes. This framework distils a complex concept into three core, measurable dimensions critical for the maintenance of engagement. It characterises elements that the system might assess to evaluate engagement more comprehensively at individual and programmatic levels, and suggests that active self-management is an important consideration to support lifelong optimal engagement. This framework could be helpful in practice to guide the development of more nuanced interventions that improve long-term treatment success and help maintain momentum in controlling a changing epidemic.
Sections du résumé
BACKGROUND
BACKGROUND
As the crisis-based approach to HIV care evolves to chronic disease management, supporting ongoing engagement with HIV care is increasingly important to achieve long-term treatment success. However, 'engagement' is a complex concept and ambiguous definitions limit its evaluation. To guide engagement evaluation and development of interventions to improve HIV outcomes, we sought to identify critical, measurable dimensions of engagement with HIV care for people on treatment from a health service-delivery perspective.
METHODS
METHODS
We used a pragmatic, iterative approach to develop a framework, combining insights from researcher experience, a narrative literature review, framework mapping, expert stakeholder input and a formal scoping review of engagement measures. These inputs helped to refine the inclusion and definition of important elements of engagement behaviour that could be evaluated by the health system.
RESULTS
RESULTS
The final framework presents engagement with HIV care as a dynamic behaviour that people practice rather than an individual characteristic or permanent state, so that people can be variably engaged at different points in their treatment journey. Engagement with HIV care for those on treatment is represented by three measurable dimensions: 'retention' (interaction with health services), 'adherence' (pill-taking behaviour), and 'active self-management' (ownership and self-management of care). Engagement is the product of wider contextual, health system and personal factors, and engagement in all dimensions facilitates successful treatment outcomes, such as virologic suppression and good health. While retention and adherence together may lead to treatment success at a particular point, this framework hypothesises that active self-management sustains treatment success over time. Thus, evaluation of all three core dimensions is crucial to realise the individual, societal and public health benefits of antiretroviral treatment programmes.
CONCLUSIONS
CONCLUSIONS
This framework distils a complex concept into three core, measurable dimensions critical for the maintenance of engagement. It characterises elements that the system might assess to evaluate engagement more comprehensively at individual and programmatic levels, and suggests that active self-management is an important consideration to support lifelong optimal engagement. This framework could be helpful in practice to guide the development of more nuanced interventions that improve long-term treatment success and help maintain momentum in controlling a changing epidemic.
Identifiants
pubmed: 37143067
doi: 10.1186/s12913-023-09433-4
pii: 10.1186/s12913-023-09433-4
pmc: PMC10161576
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
435Investigateurs
Anna Grimsrud
(A)
Beth Harley
(B)
Erin von der Heyden
(E)
Ingrid Eshun-Wilson
(I)
Ingrid Katz
(I)
Kirsten Arendse
(K)
Laura Beres
(L)
Michael Mugavero
(M)
Tali Cassidy
(T)
Tamsin Phillips
(T)
Informations de copyright
© 2023. The Author(s).
Références
PLoS One. 2019 Jan 10;14(1):e0210408
pubmed: 30629648
AIDS Patient Care STDS. 2016 Nov;30(11):497-505
pubmed: 27849372
South Afr J HIV Med. 2020 Apr 29;21(1):1054
pubmed: 32391177
PLoS Med. 2007 Oct 16;4(10):e298
pubmed: 17941716
AIDS Patient Care STDS. 2010 Oct;24(10):607-13
pubmed: 20858055
PLoS One. 2018 Mar 14;13(3):e0193641
pubmed: 29538443
J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S150-6
pubmed: 25310122
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):145-152
pubmed: 30865180
Med Encount. 2009 Spring;23(2):69-71
pubmed: 25580473
AIDS. 2010 Mar 27;24(6):915-9
pubmed: 20042849
AIDS Behav. 2017 Feb;21(2):450-461
pubmed: 27278548
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S118-S125
pubmed: 29514233
Cochrane Database Syst Rev. 2022 Jul 25;7:CD013080
pubmed: 35871531
Br J Clin Pharmacol. 2012 May;73(5):691-705
pubmed: 22486599
J Health Psychol. 2011 Oct;16(7):1071-81
pubmed: 21459919
BMJ Open. 2018 Mar 30;8(3):e020208
pubmed: 29602851
AIDS Care. 2009 Oct;21(10):1321-34
pubmed: 20024709
Ann Behav Med. 2003 Aug;26(1):1-7
pubmed: 12867348
J Int AIDS Soc. 2021 Jul;24(7):e25761
pubmed: 34292649
Trans R Soc Trop Med Hyg. 2016 Dec 1;110(12):696-704
pubmed: 28938050
PLoS Med. 2021 May 24;18(5):e1003651
pubmed: 34029346
AIDS Behav. 2020 Feb;24(2):592-606
pubmed: 30955177
Nat Commun. 2021 Jul 16;12(1):4450
pubmed: 34272399
Sociol Health Illn. 1982 Jul;4(2):167-82
pubmed: 10260456
PLoS Med. 2021 Sep 23;18(9):e1003812
pubmed: 34555010
PLoS Med. 2013;10(1):e1001369; discussion e1001369
pubmed: 23341753
BMC Infect Dis. 2020 Nov 23;20(1):879
pubmed: 33228546
Glob Public Health. 2011;6(3):247-56
pubmed: 21390970
Sex Transm Infect. 2017 Jul;93(Suppl 3):
pubmed: 28736396
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S106-SS110
pubmed: 29514232
J Int Assoc Provid AIDS Care. 2014 Jan-Feb;13(1):78-84
pubmed: 23269515
J Int AIDS Soc. 2022 Oct;25(10):e26025
pubmed: 36285618
Disabil Rehabil. 2015;37(8):643-54
pubmed: 24969698
SAHARA J. 2014;11:222-32
pubmed: 25495580
Global Health. 2011 Aug 26;7:31
pubmed: 21871074
AIDS. 2020 Apr 1;34(5):749-759
pubmed: 32004202
J Acquir Immune Defic Syndr. 2021 Mar 1;86(3):313-322
pubmed: 33149000
AIDS Patient Care STDS. 2017 May;31(5):227-236
pubmed: 28514193
J Public Health Res. 2015 Jul 16;4(2):533
pubmed: 26425494
Clin Infect Dis. 2013 Oct;57(8):1164-71
pubmed: 23797289
Am J Public Health. 2011 Feb;101(2):265-70
pubmed: 21164096
PLoS One. 2018 Jul 2;13(7):e0199977
pubmed: 29965990
Clin Epidemiol. 2019 May 07;11:359-373
pubmed: 31191029
J Int AIDS Soc. 2020 Oct;23(10):e25609
pubmed: 33030306
AIDS Care. 2016;28(5):620-7
pubmed: 26695005
J Nurs Scholarsh. 2011 Sep;43(3):255-64
pubmed: 21884371
PLoS Med. 2019 May 31;16(5):e1002811
pubmed: 31150380
Health Soc Care Community. 2021 Mar;29(2):353-368
pubmed: 32671938
J AIDS Clin Res. 2018;9(2):
pubmed: 29682399
Clin Infect Dis. 2016 Apr 1;62(7):935-944
pubmed: 26679625
Lancet HIV. 2018 Jun;5(6):e269-e270
pubmed: 29893238
Healthc (Amst). 2015 Dec;3(4):215-20
pubmed: 26699346
Int J Qual Health Care. 2014 Apr;26(2):190-7
pubmed: 24519123
Clin Infect Dis. 2011 Mar 15;52(6):793-800
pubmed: 21367734
AIDS Behav. 2018 Mar;22(3):1039-1052
pubmed: 29270789
PLoS Med. 2017 Nov 7;14(11):e1002407
pubmed: 29112692
PLoS Med. 2018 Jun 11;15(6):e1002589
pubmed: 29889844
J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):574-80
pubmed: 23011397
AIDS Behav. 2017 May;21(5):1361-1375
pubmed: 27317411
Milbank Q. 2019 Sep;97(3):659-664
pubmed: 31424130